Paving the Way towards Antisense Therapy against Duchenne Muscular Dystrophy

Publisher： Karger

E-ISSN： 1662-8063|9|4|281-281

ISSN： 1662-4246

Source： Public Health Genomics, Vol.9, Iss.4, 2006-09, pp. : 281-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy

By Li Sheng Kimura En Ng Rainer Fall Brent M. Meuse Leonard Reyes Morayma Faulkner John A. Chamberlain Jeffrey S.

Human Molecular Genetics, Vol. 15, Iss. 10, 2006-05 ,pp. : 1610-1622

Oxford University Press

Access to resources Recommend Favorite

Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy

By Ahmad A.

Human Molecular Genetics, Vol. 9, Iss. 17, 2000-10 ,pp. : 2507-2515

Oxford University Press

Access to resources Recommend Favorite

Gene therapy of muscular dystrophy

By Chamberlain J.S.

Human Molecular Genetics, Vol. 11, Iss. 20, 2002-10 ,pp. : 2355-2362

Oxford University Press

Access to resources Recommend Favorite

cDNA microarray analysis of individual Duchenne muscular dystrophy patients

By Noguchi S.

Human Molecular Genetics, Vol. 12, Iss. 6, 2003-03 ,pp. : 595-600

Oxford University Press

Access to resources Recommend Favorite

Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy

By Kleopa Kleopas A. Drousiotou Anthi Ormiston Annita Kyriakides Theodoros

Human Molecular Genetics, Vol. 15, Iss. 10, 2006-05 ,pp. : 1623-1628

Oxford University Press

Access to resources Recommend Favorite